Prior therapy defines mutation profiles in childhood cancer at relapse.

Layeghifard M, Díaz-Gay M, Bergstrom EN, Mahendralingam MJ, Light N, Blay S, Nash JO, Anderson ND, Au JN, Davidson S, Ballester PL, Wen T, Daud SK, Edward LM, Ashiqul Islam SM, Khandekar A, Otlu B, Brunga L, Hammad R, Nassif S, Thacker NH, Feltham T, Fuentes-Bolanos NA, Wong-Erasmus M, Levine MF, Miller KE, Shukla NN, Kinnaman MD, Glodzik D, Portwine C, Millson S, Zorzi AP, Mikhail M, Fernandez CV, Wheaton L, Gundem G, Kung AL, Tabori U, Mayoh C, Papaemmanuil E, Cowley MJ, Malkin D, Villani A, Alexandrov LB, Shlien A

Open source

DOI
10.1038/s41586-026-10803-1
Published
2026 Sep
Container
Nature
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41586-026-10803-1,
  title = {Prior therapy defines mutation profiles in childhood cancer at relapse.},
  author = {Layeghifard M and Díaz-Gay M and Bergstrom EN and Mahendralingam MJ and Light N and Blay S and Nash JO and Anderson ND and Au JN and Davidson S and Ballester PL and Wen T and Daud SK and Edward LM and Ashiqul Islam SM and Khandekar A and Otlu B and Brunga L and Hammad R and Nassif S and Thacker NH and Feltham T and Fuentes-Bolanos NA and Wong-Erasmus M and Levine MF and Miller KE and Shukla NN and Kinnaman MD and Glodzik D and Portwine C and Millson S and Zorzi AP and Mikhail M and Fernandez CV and Wheaton L and Gundem G and Kung AL and Tabori U and Mayoh C and Papaemmanuil E and Cowley MJ and Malkin D and Villani A and Alexandrov LB and Shlien A},
  year = {2026},
  journal = {Nature},
  doi = {10.1038/s41586-026-10803-1},
  url = {https://doi.org/10.1038/s41586-026-10803-1}
}

RIS

TY  - JOUR
TI  - Prior therapy defines mutation profiles in childhood cancer at relapse.
AU  - Layeghifard M
AU  - Díaz-Gay M
AU  - Bergstrom EN
AU  - Mahendralingam MJ
AU  - Light N
AU  - Blay S
AU  - Nash JO
AU  - Anderson ND
AU  - Au JN
AU  - Davidson S
AU  - Ballester PL
AU  - Wen T
AU  - Daud SK
AU  - Edward LM
AU  - Ashiqul Islam SM
AU  - Khandekar A
AU  - Otlu B
AU  - Brunga L
AU  - Hammad R
AU  - Nassif S
AU  - Thacker NH
AU  - Feltham T
AU  - Fuentes-Bolanos NA
AU  - Wong-Erasmus M
AU  - Levine MF
AU  - Miller KE
AU  - Shukla NN
AU  - Kinnaman MD
AU  - Glodzik D
AU  - Portwine C
AU  - Millson S
AU  - Zorzi AP
AU  - Mikhail M
AU  - Fernandez CV
AU  - Wheaton L
AU  - Gundem G
AU  - Kung AL
AU  - Tabori U
AU  - Mayoh C
AU  - Papaemmanuil E
AU  - Cowley MJ
AU  - Malkin D
AU  - Villani A
AU  - Alexandrov LB
AU  - Shlien A
PY  - 2026
JO  - Nature
DO  - 10.1038/s41586-026-10803-1
UR  - https://doi.org/10.1038/s41586-026-10803-1
ER  - 

APA

M, L., M, D., EN, B., MJ, M., N, L., S, B., JO, N., ND, A., JN, A., S, D., PL, B., T, W., SK, D., LM, E., SM, A. I., A, K., B, O., L, B., R, H., S, N., NH, T., T, F., NA, F., M, W., MF, L., KE, M., NN, S., MD, K., D, G., C, P., S, M., AP, Z., M, M., CV, F., L, W., G, G., AL, K., U, T., C, M., E, P., MJ, C., D, M., A, V., LB, A., & A, S. (2026). Prior therapy defines mutation profiles in childhood cancer at relapse.. Nature. https://doi.org/10.1038/s41586-026-10803-1

Source records